Security key
690469101
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 146,457,154
- Total 13F shares
- 38,694,424
- Share change
- +134,898
- Total reported value
- $99,783,463
- Put/Call ratio
- 1.8%
- Price per share
- $2.58
- Number of holders
- 60
- Value change
- +$651,350
- Number of buys
- 26
- Number of sells
- 21
Report period
Q1 2023
Institutions
60
Top holders
10
OVID full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Ovid Therapeutics Inc. SEC filings
Ovid Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 690469101
Recent filing periods:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
4.7%
|
6,851,051
|
$12,742,955 | — | 31 Dec 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
4.7%
|
6,828,065
|
$12,700,201 | — | 31 Dec 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
4.2%
|
6,117,400
|
$11,378,364 | — | 31 Dec 2022 | |
| Madison Avenue Partners, LP |
13F
|
Company |
1.9%
|
2,721,051
|
$5,061,155 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
2,581,736
|
$4,802,029 | — | 31 Dec 2022 | |
| Artal Group S.A. |
13F
|
Company |
1.7%
|
2,500,000
|
$4,650,000 | — | 31 Dec 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,814,562
|
$3,372,000 | — | 31 Dec 2022 | |
| TLS Advisors LLC |
13F
|
Company |
1%
|
1,490,534
|
$2,772,000 | — | 31 Dec 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.98%
|
1,430,268
|
$2,660,298 | — | 31 Dec 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
911,200
|
$1,694,832 | — | 31 Dec 2022 | |
| CHI Advisors LLC |
13F
|
Company |
0.59%
|
864,822
|
$1,608,569 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.49%
|
722,579
|
$1,343,996 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.35%
|
506,327
|
$941,769 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
499,635
|
$929,000 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.29%
|
429,156
|
$798,230 | — | 31 Dec 2022 | |
| Oasis Management Co Ltd. |
13F
|
Company |
0.18%
|
270,000
|
$502,200 | — | 31 Dec 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.18%
|
268,715
|
$499,808 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
191,733
|
$356,623 | — | 31 Dec 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.11%
|
166,041
|
$308,837 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
141,704
|
$264,000 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
119,800
|
$223,000 | — | 31 Dec 2022 | |
| Tejara Capital Ltd |
13F
|
Company |
0.07%
|
107,491
|
$199,933 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
97,324
|
$181,023 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
0.06%
|
91,400
|
$170,004 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
83,014
|
$154,406 | — | 31 Dec 2022 | |
| Boston Partners |
13F
|
Company |
0.05%
|
77,003
|
$143,230 | — | 31 Dec 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.05%
|
75,923
|
$141,217 | — | 31 Dec 2022 | |
| DCF Advisers, LLC |
13F
|
Company |
0.05%
|
70,264
|
$130,691 | — | 31 Dec 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
59,118
|
$109,959 | — | 31 Dec 2022 | |
| BANK OF NOVA SCOTIA |
13F
|
Company |
0.03%
|
45,481
|
$84,595 | — | 31 Dec 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.03%
|
39,920
|
$74,251 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
38,028
|
$70,732 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
35,704
|
$67,000 | — | 31 Dec 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.02%
|
33,832
|
$62,928 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
27,500
|
$51,000 | — | 31 Dec 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.02%
|
26,000
|
$48,360 | — | 31 Dec 2022 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
24,328
|
$45,250 | — | 31 Dec 2022 | |
| CANNELL CAPITAL LLC |
13F
|
Company |
0.02%
|
22,620
|
$42,073 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
20,316
|
$38,000 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
19,452
|
$36,181 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
16,793
|
$31,235 | — | 31 Dec 2022 | |
| Newman Dignan & Sheerar, Inc. |
13F
|
Company |
0.01%
|
15,522
|
$28,871 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
15,155
|
$28,188 | — | 31 Dec 2022 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
14,500
|
$27,000 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.01%
|
14,000
|
$26,040 | — | 31 Dec 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
13,392
|
$25,000 | — | 31 Dec 2022 | |
| BAILARD, INC. |
13F
|
Company |
0.01%
|
12,600
|
$23,436 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
12,049
|
$22,411 | — | 31 Dec 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
0.01%
|
10,009
|
$19,000 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3,541
|
$6,586 | — | 31 Dec 2022 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2023
As of 31 Mar 2023,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,694,424 shares.
The largest 10 holders included
Rubric Capital Management LP, BVF INC/IL, EcoR1 Capital, LLC, Madison Avenue Partners, LP, VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, TLS Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and CHI Advisors LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
58
Q1 2023 holders
60
Holder diff
2
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.